VC
OLMA icon

Vivo Capital’s Olema Pharmaceuticals OLMA Stock Holding History

Vivo Capital’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10M Hold
671,843
– – 0.83% 30
2025
Q4 		$16.8M Sell
671,843
-834,019
-55% -$14.8M 1.09% 27
2025
Q3 		$14.7M Hold
1,505,862
– – 1.19% 25
2025
Q2 		$6.41M Hold
1,505,862
– – 0.66% 31
2025
Q1 		$5.66M Hold
1,505,862
– – 0.75% 31
2024
Q4 		$8.78M Hold
1,505,862
– – 0.98% 23
2024
Q3 		$18M Sell
1,505,862
-367,842
-20% -$4.7M 1.49% 14
2024
Q2 		$20.3M Hold
1,873,704
– – 1.87% 13
2024
Q1 		$21.2M Hold
1,873,704
– – 1.67% 13
2023
Q4 		$26.3M Hold
1,873,704
– – 2.15% 12
2023
Q3 		$23.1M Buy
1,873,704
+534,433
+40% +$5.45M 2.54% 12
2023
Q2 		$12.1M Sell
1,339,271
-350,244
-21% -$2.11M 0.83% 20
2023
Q1 		$5.86M Hold
1,689,515
– – 0.41% 31
2022
Q4 		$4.14M Hold
1,689,515
– – 0.48% 37
2022
Q3 		$4.66M Hold
1,689,515
– – 0.51% 39
2022
Q2 		$6.88M Hold
1,689,515
– – 0.69% 31
2022
Q1 		$7.2M Hold
1,689,515
– – 0.5% 37
2021
Q4 		$15.8M Buy
1,689,515
+450,940
+36% +$9.34M 0.95% 26
2021
Q3 		$34.1M Hold
1,238,575
– – 1.53% 17
2021
Q2 		$34.7M Hold
1,238,575
– – 1.5% 17
2021
Q1 		$41.1M Hold
1,238,575
– – 1.44% 16
2020
Q4 		$59.6M Buy
+1,238,575
New +$58.1M 2.66% 10

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Vivo Capital's OLMA Position: Q1 2026 in Review

Vivo Capital held its Olema Pharmaceuticals (OLMA) position steady in Q1 2026 at 671,843 shares worth $10M. The position accounts for 0.83% of the portfolio, ranked #30.

Vivo Capital first reported a position in OLMA in Q4 2020 and has held it in 22 quarters since. The position peaked at $59.6M in Q4 2020. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Vivo Capital held 671,843 shares of Olema Pharmaceuticals worth $10M as of Q1 2026.
  • Vivo Capital left its Olema Pharmaceuticals share count unchanged in Q1 2026.
  • Olema Pharmaceuticals made up 0.83% of Vivo Capital's portfolio in Q1 2026, its #30 holding.
  • Vivo Capital first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • Vivo Capital's Olema Pharmaceuticals position peaked at $59.6M in Q4 2020.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Vivo Capital's 13F filing for Q1 2026, filed 15 May 2026.